Melvin Mann, diagnosed with chronic myeloid leukemia in 1994, participated in a clinical trial for Imatinib that extended his life by 30 years.
Treatment of sclerodermatous chronic GVHD (cGVHD) remains disappointing. Imatinib mesylate enables selective, dual inhibition of the transforming growth factor β (TGFβ) and PDGF pathways.
We evaluated the effect of LynΔN overexpression on imatinib sensitivity of the chronic myelogenous leukemia (CML) cell line K562. Therefore, we generated stable cells that express plasmids ...
Hosted on MSN1mon
Tenax Therapeutics appoints new VP of Clinical OperationsBesides levosimendan, the company may resume developing its oral formulation of imatinib. The company maintains a strong financial position with a current ratio of 38.95, indicating robust liquidity.
The study compared the MMR rate of Scemblix to investigator-selected standard-of-care tyrosine kinase inhibitors and to imatinib alone in adult patients with newly diagnosed Philadelphia ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results